The only FDA-licensed smallpox vaccine, ACAM2000 (Smallpox (Vaccinia) Vaccine, Live), will be acquired from Sanofi by Emergent BioSolutions under a recently announced deal. The move expands and diversifies Emergent’s portfolio of medical [Read more]
The Centers for Disease Control and Prevention has announced intentions to award a sole source contract to Sanofi Pasteur Biologics, LLC for the purchase of services to perform a plaque titration to [Read more]
See what we’re reading this week at Global Biodefense on topics including improving biosurveillance systems, turning competitors into collaborators during epidemics, and therapeutic windows for ricin post-exposure treatment. BIOPREPAREDNESS Using the lessons of economics [Read more]
Vaccinations have played a prominent role in U.S. military history. George Washington ordered smallpox vaccine for his soldiers during the Revolutionary War. Nearly 90 percent of the deaths of soldiers during that [Read more]
The Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases Extramural Research Program Office has announced a Cooperative Agreement effort with the Kinshasa School of Public Health [Read more]
New research suggests that smallpox, a pathogen that caused millions of deaths worldwide, may not be an ancient disease but a much more modern killer. An international team of researchers from McMaster [Read more]
See what we’re reading this week at Global Biodefense on topics including a mummy with smallpox, bioscavengers as nerve-agent countermeasures, and upcoming legal fights over vaccine refusal legislation. POLICY, PRACTICES & POLITICS What life [Read more]
Broad-spectrum antiviral Brincidofovir has shown favorable tolerability in its intravenous formulation, according to preclinical data presented by Chimerix at the American Association of Pharmaceutical Scientists‘ Annual Meeting. Brincidofovir has received Fast Track [Read more]
Bavarian Nordic, a biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases, this week announced interim financial results for the first three quarters of [Read more]
See what we’re reading this week at Global Biodefense on topics including an anthrax outbreak simulation, Ebola virus disease small molecule countermeasures, and bioterrorism threats to the water supply. BIOPREPAREDNESS UN Chief warns world [Read more]
© 2017 Global Biodefense